Related Experiment Video
Updated: May 23, 2025

In vitro Investigation of the MexAB Efflux Pump From Pseudomonas aeruginosa
Published on: February 17, 2014
Modeling substrate efflux in human P-glycoprotein at the atomic level
Yingjie Gao1, Yang Tang1, Caiyan Wei1
1Green Pharmaceutical Technology Key Laboratory of Luzhou City, Department of Medicinal Chemistry, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, China.
Human P-glycoprotein (hP-gp) actively removes drugs from cells, causing multidrug resistance. Simulations reveal how different drugs are expelled, identifying key molecular movements and pathways for developing better cancer therapies.
Area of Science:
- Biochemistry
- Molecular Biology
- Structural Biology
Background:
- Human P-glycoprotein (hP-gp) is an ATP-binding cassette (ABC) transporter crucial for xenobiotic efflux.
- hP-gp contributes significantly to multidrug resistance (MDR) in cancer, limiting therapeutic efficacy.
- The precise atomic-level mechanism of substrate translocation through hP-gp remains incompletely understood.
Purpose of the Study:
- To elucidate the molecular mechanism of substrate translocation by hP-gp using computational simulations.
- To identify molecular features and pathways that facilitate the expulsion of diverse compounds from the cell.
- To provide insights for the rational design of hP-gp inhibitors.
Main Methods:
- Steered molecular dynamics (SMD) simulations were employed to investigate hP-gp's efflux mechanism.
- Potential of Mean Force (PMF) analysis was used to determine energy landscapes of translocation.
- Structural dynamics analysis examined conformational changes during substrate transport.
Main Results:
- Translocation of vincristine was favored by the bending of transmembrane helix 1 (TM1).
- Tariquidar's high flexibility facilitated passage through the narrow exit tunnel, indicating a non-universal gate opening mechanism.
- Evidence suggests an alternating-site hydrolysis mechanism for ATP, powering TM10 transitions and interdomain communication via a conserved salt bridge.
Conclusions:
- hP-gp utilizes distinct translocation pathways and molecular dynamics for different substrates.
- ATP hydrolysis likely drives key conformational changes essential for drug efflux.
- These findings offer a deeper understanding of hP-gp function and potential strategies for overcoming MDR.
Related Concept Videos
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
The Significance of Membrane Transport
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
Hepatic Drug Clearance: Role of Transporters
Physiological Pharmacokinetic Models: Assumption with Protein Binding

